Cargando…
Emodin Alleviates Intestinal Barrier Dysfunction by Inhibiting Apoptosis and Regulating the Immune Response in Severe Acute Pancreatitis
OBJECTIVE: The intestinal barrier injury caused by severe acute pancreatitis (SAP) can induce enterogenous infection, further aggravating the inflammatory reactions and immune responses. This study aimed to test the hypothesis that emodin protects the intestinal function and is involved in the immun...
Autores principales: | Zhou, Qi, Xiang, Hong, Liu, Han, Qi, Bing, Shi, Xueying, Guo, Wenhui, Zou, Jiacheng, Wan, Xueting, Wu, Wenjing, Wang, Zhengpeng, Liu, Wenhui, Xia, Shilin, Shang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565508/ https://www.ncbi.nlm.nih.gov/pubmed/34714285 http://dx.doi.org/10.1097/MPA.0000000000001894 |
Ejemplares similares
-
Emodin Ameliorates Intestinal Dysfunction by Maintaining Intestinal Barrier Integrity and Modulating the Microbiota in Septic Mice
por: Zhang, Mina, et al.
Publicado: (2022) -
INTS8 is a therapeutic target for intrahepatic cholangiocarcinoma via the integration of bioinformatics analysis and experimental validation
por: Zhou, Qi, et al.
Publicado: (2021) -
Dietary emodin alleviates lipopolysaccharide-induced intestinal mucosal barrier injury by regulating gut microbiota in piglets
por: Xun, Wenjuan, et al.
Publicado: (2023) -
A network pharmacology-based investigation of emodin against pancreatic adenocarcinoma
por: Shi, Xueying, et al.
Publicado: (2023) -
Emodin Protects Sepsis Associated Damage to the Intestinal Mucosal Barrier Through the VDR/ Nrf2 /HO-1 Pathway
por: Shang, Luorui, et al.
Publicado: (2021)